Good Morning America co-host Robin Roberts announced on Monday that her last day on the show prior to taking a leave of absence will be on Friday. Roberts is taking the medical leave into order to receive a bone marrow transplant.
Roberts was diagnosed with MDS (myelodysplastic syndrome) earlier this year, and announced the diagnosis in June. At that time she said she would have to undergo chemotherapy and a bone marrow transplant this year as “pretreatment” for the disease. Last month she told Good Morning America viewers she anticipated taking a medical leave in late August.
The Huffington Post reports Roberts will be admitted into the hospital on Tuesday, September 4th and quoted her as telling viewers: "I'll begin the process." "It still takes about 10 days after being admitted because there are some things you have to go through before the transplant actually occurs."
ABC News says Good Morning America plans on celebrating Roberts as well as reporting extensively on her treatment, procedure and recovery process. Roberts’ doctors will be interviewed on how she is preparing for the bone marrow transplant and what she can expect the next few months.
According to the American Cancer Society, Myelodysplastic syndrome (MDS) encompasses a group of conditions that occur when the blood-forming cells in the bone marrow are damaged. Many of the blood cells that are formed by the damaged bone marrow
The Armed Forces Institute of Pathology (AFIP
Blood smear from an adult female with a myelodysplastic syndrome related to radiotherapy and chemotherapy for Hodgkin disease. A hypogranular neutrophil with a pseudo-Pelger-Huet nucleus is shown. The red blood cells show marked poikilocytosis, in part related to post-splenectomy status. (Wright-Giemsa stain)
cells are defective. The body reacts by destroying many of these abnormal blood cells, which can leave a patient with low blood counts due to a lack of normal blood cells. One-third of MDS patients develop rapidly growing cancer of bone marrow cells called acute myeloid leukemia.
The Leukemia Research Foundations estimates 12,000 new cases of MDS will be diagnosed this year.